Sandres-Saune K - Search Results

1

Genetic heterogeneity of the NS5A gene of hepatitis C virus and early response to interferon-alpha.

Boulestin A, Sandres-Saune K, Payen JL, Rostaing L, Pasquier C, Izopet J. Boulestin A, et al. J Infect Dis. 2003 Nov 1;188(9):1367-70. doi: 10.1086/379037. Epub 2003 Oct 13. J Infect Dis. 2003. PMID: 14593596

2

Evolution of human immunodeficiency virus type 1 populations after resumption of therapy following treatment interruption and shift in resistance genotype.

Izopet J, Souyris C, Hance A, Sandres-Sauné K, Alvarez M, Pasquier C, Clavel F, Puel J, Massip P. Izopet J, et al. J Infect Dis. 2002 May 15;185(10):1506-10. doi: 10.1086/340215. Epub 2002 Apr 30. J Infect Dis. 2002. PMID: 11992288

3

Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon-alpha.

Boulestin A, Sandres-Sauné K, Payen JL, Alric L, Dubois M, Pasquier C, Vinel JP, Pascal JP, Puel J, Izopet J. Boulestin A, et al. J Med Virol. 2002 Oct;68(2):221-8. doi: 10.1002/jmv.10192. J Med Virol. 2002. PMID: 12210411 Clinical Trial.

4

Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation.

Kamar N, Toupance O, Buchler M, Sandres-Saune K, Izopet J, Durand D, Rostaing L. Kamar N, et al. J Am Soc Nephrol. 2003 Aug;14(8):2092-8. doi: 10.1097/01.asn.0000079613.81511.3c. J Am Soc Nephrol. 2003. PMID: 12874463

5

Convenient biological assay for polyethylene glycol-interferons in patients with hepatitis C.

Boulestin A, Kamar N, Legrand-Abravanel F, Sandres-Saune K, Alric L, Vinel JP, Rostaing L, Izopet J. Boulestin A, et al. Antimicrob Agents Chemother. 2004 Sep;48(9):3610-2. doi: 10.1128/AAC.48.9.3610-3612.2004. Antimicrob Agents Chemother. 2004. PMID: 15328140 Free PMC article.

6

Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France.

Nicot F, Legrand-Abravanel F, Sandres-Saune K, Boulestin A, Dubois M, Alric L, Vinel JP, Pasquier C, Izopet J. Nicot F, et al. J Gen Virol. 2005 Jan;86(Pt 1):107-114. doi: 10.1099/vir.0.80409-0. J Gen Virol. 2005. PMID: 15604436

7

Evolution of hepatitis C virus quasispecies during therapy with IL2 combinated to alpha interferon and ribavirin.

Boulestin A, Sandres-Saune K, Alric L, Pipy B, Dubois M, Vinel JP, Izopet J. Boulestin A, et al. Antivir Ther. 2005;10(4):499-504. Antivir Ther. 2005. PMID: 16038475

8

Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.

Boulestin A, Kamar N, Sandres-Sauné K, Legrand-Abravanel F, Alric L, Vinel JP, Rostaing L, Izopet J. Boulestin A, et al. J Med Virol. 2006 Mar;78(3):365-71. doi: 10.1002/jmv.20548. J Med Virol. 2006. PMID: 16419107

9

Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France.

Legrand-Abravanel F, Kamar N, Sandres-Saune K, Garrouste C, Dubois M, Mansuy JM, Muscari F, Sallusto F, Rostaing L, Izopet J. Legrand-Abravanel F, et al. J Infect Dis. 2010 Sep 15;202(6):835-44. doi: 10.1086/655899. J Infect Dis. 2010. PMID: 20695798

10

Temporal evolution of the distribution of hepatitis E virus genotypes in Southwestern France.

Lhomme S, Abravanel F, Dubois M, Chapuy-Regaud S, Sandres-Saune K, Mansuy JM, Rostaing L, Kamar N, Izopet J. Lhomme S, et al. Among authors: sandres saune k. Infect Genet Evol. 2015 Oct;35:50-5. doi: 10.1016/j.meegid.2015.07.028. Epub 2015 Jul 26. Infect Genet Evol. 2015. PMID: 26218544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters